Woodline Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-155,883
| Closed | -$7.04M | – | 1006 |
|
|
2024
Q4 | $7.04M | Buy |
+155,883
| New | +$7.04M | 0.05% | 416 |
|
|
2024
Q1 | – | Sell |
-226,942
| Closed | -$6.25M | – | 614 |
|
|
2023
Q4 | $6.25M | Buy |
+226,942
| New | +$6.25M | 0.07% | 288 |
|
|
2023
Q2 | – | Sell |
-421,393
| Closed | -$20.4M | – | 725 |
|
|
2023
Q1 | $20.4M | Buy |
421,393
+309,192
| +276% | +$15M | 0.28% | 99 |
|
|
2022
Q4 | $4.28M | Sell |
112,201
-668,336
| -86% | -$25.5M | 0.06% | 341 |
|
|
2022
Q3 | $39.2M | Buy |
780,537
+535,277
| +218% | +$26.9M | 0.55% | 32 |
|
|
2022
Q2 | $9.83M | Buy |
245,260
+36,767
| +18% | +$1.47M | 0.15% | 179 |
|
|
2022
Q1 | $7.78M | Sell |
208,493
-327,451
| -61% | -$12.2M | 0.13% | 198 |
|
|
2021
Q4 | $21.3M | Sell |
535,944
-23,850
| -4% | -$950K | 0.31% | 84 |
|
|
2021
Q3 | $20.8M | Buy |
559,794
+216,343
| +63% | +$8.05M | 0.34% | 78 |
|
|
2021
Q2 | $14.5M | Buy |
343,451
+81,917
| +31% | +$3.46M | 0.27% | 99 |
|
|
2021
Q1 | $12.4M | Buy |
261,534
+141,063
| +117% | +$6.68M | 0.27% | 98 |
|
|
2020
Q4 | $7.35M | Sell |
120,471
-172,139
| -59% | -$10.5M | 0.2% | 134 |
|
|
2020
Q3 | $13.7M | Buy |
292,610
+110,900
| +61% | +$5.18M | 0.45% | 66 |
|
|
2020
Q2 | $9.22M | Sell |
181,710
-53,576
| -23% | -$2.72M | 0.37% | 77 |
|
|
2020
Q1 | $10.5M | Sell |
235,286
-81,940
| -26% | -$3.66M | 0.75% | 43 |
|
|
2019
Q4 | $15.2M | Buy |
+317,226
| New | +$15.2M | 0.62% | 54 |
|